Nicholas C. Ling
36Patents
15h-index
35Co-inventors
81Inventor score
Filing activity: Nov 8, 1979 → Aug 9, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5155214A | Basic fibroblast growth factor | Human Necessities | 84 | Expired |
| US4973577A | FSH-releasing peptides | Human Necessities | 83 | Expired |
| US4316891A | Extended N-terminal somatostatin | Emerging Cross-Sectional Technologies | 64 | Expired |
| US6251396A | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | Human Necessities | 40 | Expired |
| US6197926A | Methods for treatment of diabetes using peptide analogues of insulin | Human Necessities | 35 | Expired |
| US4956455A | Bovine fibroblast growth factor | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5132408A | Fibroblast growth factor antagonists | Human Necessities | 33 | Expired |
| US5041538A | Mammalian follistatin | Chemistry; Metallurgy | 33 | Expired |
| US4517181A | Mammalian PGRF | Emerging Cross-Sectional Technologies | 26 | Expired |
| US4610976A | Porcine GRF | Emerging Cross-Sectional Technologies | 20 | Expired |
| US4585756A | Bovine GRF | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5464774A | Bovine basic fibroblast growth factor | Human Necessities | 18 | Expired |
| US4740587A | Inhibin and method of purifying same | Emerging Cross-Sectional Technologies | 17 | Expired |
| US4605643A | Ovine GRF | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5182375A | DNA encoding follistatin | Chemistry; Metallurgy | 16 | Expired |
| US5252718A | Fibroblast growth factor antagonists | Emerging Cross-Sectional Technologies | 13 | Expired |
| US4409139A | Gonadostatin | Human Necessities | 10 | Expired |
| US5948764A | Methods for treatment of multiple sclerosis utilizing peptide analogues of human myelin basic protein | Human Necessities | 10 | Expired |
| US4280953A | Glycosylated analogs of somatostatin | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6004775A | DNA encoding IGFBP-4 | Human Necessities | 8 | Expired |
| US6379670B1 | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | Human Necessities | 7 | Expired |
| US8519096B2 | Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis | Chemistry; Metallurgy | 7 | Active |
| US9062096B2 | HER2Delta16 peptides | Chemistry; Metallurgy | 4 | Active |
| US6329499A | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein | Human Necessities | 4 | Expired |
| US9630993B2 | HER2Delta16 peptides | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.